D1 dopamine receptor agonists mediate activation of p38 mitogen- activated protein kinase and c-Jun amino-terminal kinase by a protein kinase A-dependent mechanism in SK-N-MC human neuroblastoma cells

Molecular Pharmacology

Volumn 54, Issue 3, 1998, Pages 453-458

  Zhen, Xuechu ^a   Uryu, Kunihiro ^a   Wang, Hoau Yan ^a   Friedman, Eitan ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; BUCLADESINE; CALPHOSTIN C; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DERIVATIVE; DIHYDREXIDINE; DOPAMINE 1 RECEPTOR BLOCKING AGENT; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; QUINPIROLE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE P38; PHENANTHRIDINE DERIVATIVE; PROTEIN KINASE (CALCIUM,CALMODULIN); STRESS ACTIVATED PROTEIN KINASE;

ARTICLE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; CELL CULTURE; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; KINETICS; METABOLISM; NEUROBLASTOMA; PHOSPHORYLATION; PHYSIOLOGY;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE AGONISTS; ENZYME ACTIVATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; MITOGEN-ACTIVATED PROTEIN KINASES; NEUROBLASTOMA; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHENANTHRIDINES; PHOSPHORYLATION; RECEPTORS, DOPAMINE D1; TUMOR CELLS, CULTURED;

EID: 0031595680     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.54.3.453     Document Type: Article

References (35)

1. βγ-mediated MAP kinase activation by a common signaling pathway. Nature (Lond) 376:781-784.
2. Cleasson-Welsh L (1994) Platelet-derived growth factor receptor signals. J Biol Chem 269:32023-32026.
3. Cobbs MH and Goldsmith EJ (1995) How MAP kinases are regulated. J Biol Chem 270:14843-14846.
4. Crespo P, Cachero TG, Xu N, and Gutkind JS (1995) Dual effect of β-adrenergic receptors on mitogen-activated protein kinase. J Biol Chem 270:25259-25265.
5. 2-adrenergic receptor to different G proteins by protein kinase A. Nature (Lond) 390:88-91.
6. Faure M, Voyno-Yasenetskaya TA, and Bourne HH (1994) cAMP and βγ subunits of heterotrimeric G proteins stimulate the mitogen-activated protein kinase pathway in COS-7 cells. J Biol Chem 269:7851-7854.
7. Gilmore JH, Watts VJ, Lawler CP, Noll EP, Nichols DE, and Mailman RB (1995) "Full" dopamine D1 agonists in human caudate: biochemical properties and therapeutic implication. Neuropharmacology 34:481-488.
8. Graves JD, Draves KE, Craxton A, Saklatvala J, Rrebs EG, and Clark EA (1996) Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci USA 93:13814-13818.
9. Israel MM, Jaquet P, and Vincent JD (1985) The electrical properties of isolated human prolactin-secreting adenoma cells and their modification by dopamine. Endocrinology 117:1448-1455.
10. α13 and obligate for differentiation of p19 embryonal carcinoma cells by retinoic acid. J Biol Chem 272:24468-24474.
11. Johnson GL and Vaillancourt RR (1994) Sequential protein kinase reactions controlling cell growth and differentiation. Curr Opin Cell Biol 6:230-238.
12. Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, and Nishida E (1997) Activation and involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in rat cerebellar granule cells. J Biol Chem 272: 18518-18521.
13. ras. Proc Natl Acad Sci USA 91:12701-12706.
14. Lajiness ME, Chio CL, and Huff R (1993) D2 dopamine receptor stimulation of mitogenesis in transfected Chinese hamster ovary cells: Relationship to dopamine stimulation of tyrosine phosphorylations. J Pharmacol Exp Ther 267:1573-1581.
15. Lim R and Zaheer A (1996) In vitro enhancement of p38 mitogen-activated protein kinase activity by phosphorylated glia maturation factor. J Biol Chem 271:22953-22956.
16. Luo Y, Umegaki H, Wang X, Abe R, and Roth GS (1998) Dopamine induced apoptosis through an oxidation-involved SAPK/JNK activation pathway. J Biol Chem 273: 3756-3764.
17. 1/S through a mechanism requiring p38/RK. J Biol Chem 272:13229-13235.
18. Paul A, Wilson S, Belham CM, Robinson CJM, Scott PH, Gould GW, and Plevin R (1997) Stress-activated protein kinases: activation, regulation and function. Cell Signal 9:403-410.
19. Post GR and Brown JH (1996) G protein-coupled receptors and signaling pathways regulating growth responses. FASEB J 10:741-749.
20. Rao GN and Runge MS (1996) Cyclic AMP inhibition of thrombin-induced growth in vascular smooth muscle cells correlates with decreased JNK1 activity and c-Jun expression. J Biol Chem 271:20805-20810.
21. Rogue P and Malviya A (1994) Regulations of signaling pathways to the nucleus by dopaminergic receptors. Cell Signal 6:725-733.
22. Silva JD, Pierrat B, Mary JL, and Lesslauer W (1997) Blockade of p38 mitogen-activated protein kinase pathway inhibits inducible nitric-oxide synthase expression in mouse astrocytes. J Biol Chem 272:28373-28380.
23. Taussig R, Quarmby LM, and Gilman AG (1993) Regulation of purified and I and II adenylyl cyclases by G protein βγ subunits. J Biol Chem 268:9-12.
24. Treisman R (1996) Regulation of transcription by MAP kinase cascades. Curr Opin Cell Biol 8:205-215.
25. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, and Kolesnick RN (1996) Requirement for ceramide-initiated SAPK/JNK signaling in stress-induced apoptosis. Nature (Lond) 380:75-79.
26. α13 regulate extracellular signal-regulated kinase and c-Jun kinase pathways by different mechanisms in COS-7 cells. J Biol Chem 271:21081-21087.
27. Walkinshaw G and Waters CM (1995) Induction of apoptosis in catecholaminergic PC12 cells by L-DOPA: implications for the treatment of Parkinson's disease. J Clin. Invest 95:2458-2464.
28. Wan Y, Kurosaki T, and Huang XY (1996) Tyrosine kinases in activation of the MAP kinases cascade by G-protein-coupled receptors. Nature (Lond) 380:541-543.
29. q protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Mol Pharmacol 48:988-994.
30. Wu J, Dent P, Jenikek T, Wolfman A, Weber MJ, and Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science (Washington DC) 262:1065-1069.
31. Xia Z, Dickens M, Raingeaud J, Davis RJ, and Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science (Washington DC) 270: 1326-1331.
32. q/11 subunits. J Biol Chem 272:27771-27777.
33. q-mediated activation of mitogen-activated protein kinase and phosphoinositide synthesis. J Biol Chem 272:11924-11927.
34. Yasunari K, Kohno K, Kano H, Yokokawa K, Minami M, and Yoshikawa J (1997) Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells. Hypertension (Dallas) 29:350-355.
35. 1A receptor regulation of phospholipase C isoform. J Biol Chem 271: 19503-19508.